Cargando…
Development of kinomic analyses to identify dysregulated signaling pathways in cells expressing cytoplasmic PrP
BACKGROUND: Dysregulated protein kinase signaling is involved in the pathogenesis of many chronic diseases. However, the dysregulated signaling pathways critical to prion pathogenesis remain incompletely characterized. Global analyses of signaling pathways may be useful to better characterize these...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283144/ https://www.ncbi.nlm.nih.gov/pubmed/25280966 http://dx.doi.org/10.1186/1743-422X-11-175 |
_version_ | 1782351224580866048 |
---|---|
author | Shott, Rory H Appanah, Cathy Grenier, Catherine Tremblay, Guillaume Roucou, Xavier Schang, Luis M |
author_facet | Shott, Rory H Appanah, Cathy Grenier, Catherine Tremblay, Guillaume Roucou, Xavier Schang, Luis M |
author_sort | Shott, Rory H |
collection | PubMed |
description | BACKGROUND: Dysregulated protein kinase signaling is involved in the pathogenesis of many chronic diseases. However, the dysregulated signaling pathways critical to prion pathogenesis remain incompletely characterized. Global analyses of signaling pathways may be useful to better characterize these pathways. We therefore set out to develop such global assays. To this end, we used as a model cytoplasmic mutants of the cellular prion protein (PrP(C)), which are toxic to N2a neuroblastoma cells. We tested the global assays for their sensitivity to detect changes in signaling pathways in cells expressing cytoplasmic PrP mutants. METHODS: We developed a targeted proteomics (kinomics) approach using multiplex Western blots to identify signaling pathways dysregulated in chronic neurological pathologies. We tested the approach for its potential ability to detect signaling changes in N2a cells expressing cytoplasmic PrP mutants. RESULTS: Multiplex Western blots were designed to quantitate the expression levels of 137 protein kinases in a single membrane and using only 1.2 mg of sample. The response of the blots was sensitive and linear to changes of 6% in protein levels. Hierarchical and functional clustering of the relative expression levels identified an mTOR signaling pathway as potentially dysregulated in N2a cells expressing cytoplasmic PrP. The mTOR signaling pathway regulates global protein synthesis, which is inhibited in cells expressing cytoplasmic PrP. The levels of proteins involved in the Akt1/p70S6K branch of mTOR signaling changed in synchrony with time of cytoplasmic PrP expression. Three kinases in this pathway, Akt, p70S6K, and eIF4B were in their inactive states, as evaluated by phosphorylation of their regulatory sites. CONCLUSION: The results presented are consistent with the previously reported inhibition of Akt/p70S6K/eIF4B signaling as mediating pathogenesis of cytoplasmic PrP. We conclude that the kinomic analyses are sensitive and specific to detect signaling pathways dysregulated in a simple in vitro model of PrP pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1743-422X-11-175) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4283144 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42831442015-01-06 Development of kinomic analyses to identify dysregulated signaling pathways in cells expressing cytoplasmic PrP Shott, Rory H Appanah, Cathy Grenier, Catherine Tremblay, Guillaume Roucou, Xavier Schang, Luis M Virol J Research BACKGROUND: Dysregulated protein kinase signaling is involved in the pathogenesis of many chronic diseases. However, the dysregulated signaling pathways critical to prion pathogenesis remain incompletely characterized. Global analyses of signaling pathways may be useful to better characterize these pathways. We therefore set out to develop such global assays. To this end, we used as a model cytoplasmic mutants of the cellular prion protein (PrP(C)), which are toxic to N2a neuroblastoma cells. We tested the global assays for their sensitivity to detect changes in signaling pathways in cells expressing cytoplasmic PrP mutants. METHODS: We developed a targeted proteomics (kinomics) approach using multiplex Western blots to identify signaling pathways dysregulated in chronic neurological pathologies. We tested the approach for its potential ability to detect signaling changes in N2a cells expressing cytoplasmic PrP mutants. RESULTS: Multiplex Western blots were designed to quantitate the expression levels of 137 protein kinases in a single membrane and using only 1.2 mg of sample. The response of the blots was sensitive and linear to changes of 6% in protein levels. Hierarchical and functional clustering of the relative expression levels identified an mTOR signaling pathway as potentially dysregulated in N2a cells expressing cytoplasmic PrP. The mTOR signaling pathway regulates global protein synthesis, which is inhibited in cells expressing cytoplasmic PrP. The levels of proteins involved in the Akt1/p70S6K branch of mTOR signaling changed in synchrony with time of cytoplasmic PrP expression. Three kinases in this pathway, Akt, p70S6K, and eIF4B were in their inactive states, as evaluated by phosphorylation of their regulatory sites. CONCLUSION: The results presented are consistent with the previously reported inhibition of Akt/p70S6K/eIF4B signaling as mediating pathogenesis of cytoplasmic PrP. We conclude that the kinomic analyses are sensitive and specific to detect signaling pathways dysregulated in a simple in vitro model of PrP pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1743-422X-11-175) contains supplementary material, which is available to authorized users. BioMed Central 2014-10-03 /pmc/articles/PMC4283144/ /pubmed/25280966 http://dx.doi.org/10.1186/1743-422X-11-175 Text en © Shott et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Shott, Rory H Appanah, Cathy Grenier, Catherine Tremblay, Guillaume Roucou, Xavier Schang, Luis M Development of kinomic analyses to identify dysregulated signaling pathways in cells expressing cytoplasmic PrP |
title | Development of kinomic analyses to identify dysregulated signaling pathways in cells expressing cytoplasmic PrP |
title_full | Development of kinomic analyses to identify dysregulated signaling pathways in cells expressing cytoplasmic PrP |
title_fullStr | Development of kinomic analyses to identify dysregulated signaling pathways in cells expressing cytoplasmic PrP |
title_full_unstemmed | Development of kinomic analyses to identify dysregulated signaling pathways in cells expressing cytoplasmic PrP |
title_short | Development of kinomic analyses to identify dysregulated signaling pathways in cells expressing cytoplasmic PrP |
title_sort | development of kinomic analyses to identify dysregulated signaling pathways in cells expressing cytoplasmic prp |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283144/ https://www.ncbi.nlm.nih.gov/pubmed/25280966 http://dx.doi.org/10.1186/1743-422X-11-175 |
work_keys_str_mv | AT shottroryh developmentofkinomicanalysestoidentifydysregulatedsignalingpathwaysincellsexpressingcytoplasmicprp AT appanahcathy developmentofkinomicanalysestoidentifydysregulatedsignalingpathwaysincellsexpressingcytoplasmicprp AT greniercatherine developmentofkinomicanalysestoidentifydysregulatedsignalingpathwaysincellsexpressingcytoplasmicprp AT tremblayguillaume developmentofkinomicanalysestoidentifydysregulatedsignalingpathwaysincellsexpressingcytoplasmicprp AT roucouxavier developmentofkinomicanalysestoidentifydysregulatedsignalingpathwaysincellsexpressingcytoplasmicprp AT schangluism developmentofkinomicanalysestoidentifydysregulatedsignalingpathwaysincellsexpressingcytoplasmicprp |